MedTrace Logo

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis

NCT06298617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-03-12

No results posted yet for this study

Summary

Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and is characterized by the presence and growth of endometrial-like glandular epithelial and stromal cells outside the uterus leading to multiple clinical symptoms affecting patients quality of life and fertility with high recurrence rate . The systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies for various cancers .

Conditions

  • Endometriosis

Interventions

PROCEDURE

Diagnostic laparoscopy

All women will undergo exploratory laparoscopy under general anesthesia

DIAGNOSTIC_TEST

Full Blood Count (FBC)

Blood samples withdrawn from patients on EDITA tubes and gone through full blood count and differential leucocytic count

Sponsors & Collaborators

  • Benha University

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-07-30
Completion
2023-12-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06298617 on ClinicalTrials.gov